Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 056428/0797 | |
| Pages: | 7 |
| | Recorded: | 06/03/2021 | | |
Attorney Dkt #: | 11450278US4 |
Conveyance: | MERGER AND CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
1
|
|
Patent #:
|
|
Issue Dt:
|
06/14/2022
|
Application #:
|
16662126
|
Filing Dt:
|
10/24/2019
|
Publication #:
|
|
Pub Dt:
|
02/03/2022
| | | | |
Title:
|
ANTAGONIST OF THE FIBROBLAST GROWTH FACTOR RECEPTOR 3 (FGFR3) FOR USE IN THE TREATMENT OR THE PREVENTION OF SKELETAL DISORDERS LINKED WITH ABNORMAL ACTIVATION OF FGFR3
|
|
Assignors
|
|
|
|
|
|
|
Newly Merged Entity Data
|
|
|
|
Newly Merged Entity's New Name
|
|
|
85 BOULEVARD SAINT-GERMAIN |
PARIS, FRANCE 75006 |
|
Correspondence name and address
|
|
W&C IP
|
|
11491 SUNSET HILLS ROAD
|
|
SUITE 340
|
|
RESTON, VA 20190
|
Search Results as of:
06/23/2024 10:50 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|